Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949409381> ?p ?o ?g. }
- W2949409381 abstract "Nudix Hydrolase 15 (NUDT15) and Thiopurine S-Methyltransferase (TPMT) are strong genetic determinants of thiopurine toxicity in pediatric acute lymphoblastic leukemia (ALL) patients. Since patients with NUDT15 or TPMT deficiency suffer severe adverse drug reactions, star (*) allele-based haplotypes have been used to predict an optimal 6-mercaptopurine (6-MP) dosing. However, star allele haplotyping suffers from insufficient, inconsistent, and even conflicting designations with uncertain and/or unknown functional alleles. Gene-wise variant burden (GVB) scoring enables us to utilize next-generation sequencing (NGS) data to predict 6-MP intolerance in children with ALL. Whole exome sequencing was performed for 244 pediatric ALL patients under 6-MP treatments. We assigned star alleles with PharmGKB haplotype set translational table. GVB for NUDT15 and TPMT was computed by aggregating in silico deleteriousness scores of multiple coding variants for each gene. Poor last-cycle dose intensity percent (DIP < 25%) was considered as 6-MP intolerance, resulting therapeutic failure of ALL. DIPs showed significant differences ( p < 0.05) among NUDT15 poor (PM, n = 1), intermediate (IM, n = 48), and normal (NM, n = 195) metabolizers. TPMT exhibited no PM and only seven IMs. GVB showed significant differences among the different haplotype groups of both NUDT15 and TPMT ( p < 0.05). Kruskal-Wallis test for DIP values showed statistical significances for the seven different GVB score bins of NUDT15. GVB NUDT15 outperformed the star allele-based haplotypes in predicting patients with reduced last-cycle DIPs at all DIP threshold levels (i.e., 5%, 10%, 15%, and 25%). In NUDT15-and-TPMT combined interaction analyses, GVB NUDT15,TPMT outperformed star alleles [area under the receiver operating curve (AUROC) = 0.677 vs. 0.645] in specificity (0.813 vs. 0.796), sensitivity (0.526 vs. 0.474), and positive (0.192 vs. 0.164) and negative (0.953 vs. 0.947) predictive values. Overall, GVB correctly classified five more patients (i.e., one into below and four into above 25% DIP groups) than did star allele haplotypes. GVB analysis demonstrated that 6-MP intolerance in pediatric ALL can be reliably predicted by aggregating NGS-based common, rare, and novel variants together without hampering the predictive power of the conventional haplotype analysis." @default.
- W2949409381 created "2019-06-27" @default.
- W2949409381 creator A5006594079 @default.
- W2949409381 creator A5044005599 @default.
- W2949409381 creator A5048011214 @default.
- W2949409381 creator A5048695610 @default.
- W2949409381 creator A5064771213 @default.
- W2949409381 creator A5076407059 @default.
- W2949409381 creator A5079630547 @default.
- W2949409381 creator A5083854194 @default.
- W2949409381 creator A5087839513 @default.
- W2949409381 date "2019-06-11" @default.
- W2949409381 modified "2023-09-24" @default.
- W2949409381 title "Star Allele-Based Haplotyping versus Gene-Wise Variant Burden Scoring for Predicting 6-Mercaptopurine Intolerance in Pediatric Acute Lymphoblastic Leukemia Patients" @default.
- W2949409381 cites W1550975458 @default.
- W2949409381 cites W1821033833 @default.
- W2949409381 cites W1883211128 @default.
- W2949409381 cites W1964947822 @default.
- W2949409381 cites W1969692023 @default.
- W2949409381 cites W1977626786 @default.
- W2949409381 cites W1982556402 @default.
- W2949409381 cites W1984068087 @default.
- W2949409381 cites W2006617902 @default.
- W2949409381 cites W2007733142 @default.
- W2949409381 cites W2031082289 @default.
- W2949409381 cites W2063280109 @default.
- W2949409381 cites W2064928200 @default.
- W2949409381 cites W2071861051 @default.
- W2949409381 cites W2074024827 @default.
- W2949409381 cites W2109000403 @default.
- W2949409381 cites W2110755408 @default.
- W2949409381 cites W2114185635 @default.
- W2949409381 cites W2143238378 @default.
- W2949409381 cites W2145648574 @default.
- W2949409381 cites W2160995259 @default.
- W2949409381 cites W2168133698 @default.
- W2949409381 cites W2169228559 @default.
- W2949409381 cites W2275947820 @default.
- W2949409381 cites W2316734434 @default.
- W2949409381 cites W2512562938 @default.
- W2949409381 cites W2525462428 @default.
- W2949409381 cites W2594576154 @default.
- W2949409381 cites W2731117318 @default.
- W2949409381 cites W2774752511 @default.
- W2949409381 cites W2789947395 @default.
- W2949409381 cites W2801930955 @default.
- W2949409381 cites W2900673338 @default.
- W2949409381 doi "https://doi.org/10.3389/fphar.2019.00654" @default.
- W2949409381 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6580331" @default.
- W2949409381 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31244663" @default.
- W2949409381 hasPublicationYear "2019" @default.
- W2949409381 type Work @default.
- W2949409381 sameAs 2949409381 @default.
- W2949409381 citedByCount "15" @default.
- W2949409381 countsByYear W29494093812020 @default.
- W2949409381 countsByYear W29494093812021 @default.
- W2949409381 countsByYear W29494093812022 @default.
- W2949409381 countsByYear W29494093812023 @default.
- W2949409381 crossrefType "journal-article" @default.
- W2949409381 hasAuthorship W2949409381A5006594079 @default.
- W2949409381 hasAuthorship W2949409381A5044005599 @default.
- W2949409381 hasAuthorship W2949409381A5048011214 @default.
- W2949409381 hasAuthorship W2949409381A5048695610 @default.
- W2949409381 hasAuthorship W2949409381A5064771213 @default.
- W2949409381 hasAuthorship W2949409381A5076407059 @default.
- W2949409381 hasAuthorship W2949409381A5079630547 @default.
- W2949409381 hasAuthorship W2949409381A5083854194 @default.
- W2949409381 hasAuthorship W2949409381A5087839513 @default.
- W2949409381 hasBestOaLocation W29494093811 @default.
- W2949409381 hasConcept C104317684 @default.
- W2949409381 hasConcept C126322002 @default.
- W2949409381 hasConcept C135763542 @default.
- W2949409381 hasConcept C143998085 @default.
- W2949409381 hasConcept C180754005 @default.
- W2949409381 hasConcept C197754878 @default.
- W2949409381 hasConcept C2776760755 @default.
- W2949409381 hasConcept C2777173762 @default.
- W2949409381 hasConcept C2779134260 @default.
- W2949409381 hasConcept C54355233 @default.
- W2949409381 hasConcept C55775858 @default.
- W2949409381 hasConcept C70917649 @default.
- W2949409381 hasConcept C71924100 @default.
- W2949409381 hasConcept C86803240 @default.
- W2949409381 hasConceptScore W2949409381C104317684 @default.
- W2949409381 hasConceptScore W2949409381C126322002 @default.
- W2949409381 hasConceptScore W2949409381C135763542 @default.
- W2949409381 hasConceptScore W2949409381C143998085 @default.
- W2949409381 hasConceptScore W2949409381C180754005 @default.
- W2949409381 hasConceptScore W2949409381C197754878 @default.
- W2949409381 hasConceptScore W2949409381C2776760755 @default.
- W2949409381 hasConceptScore W2949409381C2777173762 @default.
- W2949409381 hasConceptScore W2949409381C2779134260 @default.
- W2949409381 hasConceptScore W2949409381C54355233 @default.
- W2949409381 hasConceptScore W2949409381C55775858 @default.
- W2949409381 hasConceptScore W2949409381C70917649 @default.
- W2949409381 hasConceptScore W2949409381C71924100 @default.
- W2949409381 hasConceptScore W2949409381C86803240 @default.
- W2949409381 hasFunder F4320322014 @default.
- W2949409381 hasLocation W29494093811 @default.
- W2949409381 hasLocation W29494093812 @default.